Please use this identifier to cite or link to this item: http://repository.kln.ac.lk/handle/123456789/2035
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBlacksell, S.D.en_US
dc.contributor.authorTanganuchitcharnchai, A.en_US
dc.contributor.authorJarman, R.G.en_US
dc.contributor.authorGibbons, R.V.en_US
dc.contributor.authorParis, D.H.en_US
dc.contributor.authorBailey, M.S.en_US
dc.contributor.authorDay, N.P.en_US
dc.contributor.authorPremaratna, R.en_US
dc.contributor.authorLalloo, D.G.en_US
dc.contributor.authorde Silva, H.J.en_US
dc.date.accessioned2014-10-29T09:32:15Z-
dc.date.available2014-10-29T09:32:15Z-
dc.date.issued2011en_US
dc.identifier.citationClinical and Vaccine Immunology; 18(10): pp.1773-75en_US
dc.identifier.issn1556-6811 (Print)en_US
dc.identifier.issn1556-679X (Electronic)en_US
dc.identifier.urihttp://repository.kln.ac.lk/handle/123456789/2035-
dc.description.abstractA Sri Lankan fever cohort (n = 292 patients; 17.8% prevalence) was used to assess two standard diagnostic Chikungunya IgM tests. The immunochromatographic test (ICT) acute sample sensitivity (SN) was 1.9 to 3.9%, and specificity (SP) was 92.5 to 95.0%. The enzyme-linked immunosorbent assay (ELISA) gave an acute sample SN of 3.9% and an SP of 92.5% and a convalescent sample SN of 84% and an SP of 91%. These assays are not suitable for the acute diagnosis of Chikungunya virus infection.-
dc.publisherAmerican Society for Microbiologyen_US
dc.titlePoor diagnostic accuracy of commercial antibody-based assays for the diagnosis of acute Chikungunya infectionen_US
dc.typeArticleen_US
dc.creator.corporateauthorAmerican Society for Microbiologyen_US
Appears in Collections:Journal/Magazine Articles

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.